Judy L. Smith

1.0k total citations
23 papers, 541 citations indexed

About

Judy L. Smith is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Judy L. Smith has authored 23 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Judy L. Smith's work include Esophageal Cancer Research and Treatment (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Judy L. Smith is often cited by papers focused on Esophageal Cancer Research and Treatment (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Judy L. Smith collaborates with scholars based in United States. Judy L. Smith's co-authors include Hector Nava, Harold O. Douglass, John F. Gibbs, Hank C. Hill, Nicholas J. Petrelli, Quyen D. Chu, Deborah Driscoll, Don C. Bienfang, Michael S. Sabel and Miguel A. Rodrı́guez-Bigas and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Judy L. Smith

22 papers receiving 522 citations

Peers

Judy L. Smith

SURGE

ONCOL

EPIDE

PRM

NEURO

Gaurav Malhotra India

Anthie Papadopoulou United Kingdom

Bedii Kanmaz Türkiye

Cristian Rapicetta Italy

Enrico Tucci Italy

R.C.J. Verschueren Netherlands

Tanya Levine United Kingdom

Varun Singh Dhull India

Osama Al‐Saif Saudi Arabia

Elgin Özkan Türkiye

Gaurav Malhotra India

Judy L. Smith

196 ×0.8

SURGE

169 ×0.7

ONCOL

114 ×0.6

EPIDE

189 ×1.0

PRM

68 ×0.5

NEURO

Citations per year, relative to Judy L. Smith Judy L. Smith (= 1×) peers Gaurav Malhotra

Countries citing papers authored by Judy L. Smith

Since Specialization

Citations

This map shows the geographic impact of Judy L. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy L. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy L. Smith more than expected).

Fields of papers citing papers by Judy L. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy L. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy L. Smith. The network helps show where Judy L. Smith may publish in the future.

Co-authorship network of co-authors of Judy L. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Judy L. Smith. A scholar is included among the top collaborators of Judy L. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy L. Smith. Judy L. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kerr, David, Janet Dunn, M J Langman, et al.. (2008). VICTOR: A phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection. Journal of Clinical Oncology. 26(15_suppl). 4038–4038. 2 indexed citations

Ahluwalia, Manmeet S., Kimberly Klein, Boris W. Kuvshinoff, et al.. (2008). Improving Compliance with Guidelines for Venous Thromboembolism (VTE) Prophylaxis Significantly Reduces VTE Events.. Blood. 112(11). 1288–1288. 1 indexed citations

Javle, Milind, Chukwumere Nwogu, Kathleen Donohue, et al.. (2006). Management of locoregional stage esophageal cancer: a single center experience. Diseases of the Esophagus. 19(2). 78–83. 10 indexed citations

Fakih, Marwan, Ashwani Rajput, Gary Yang, et al.. (2006). A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 65(5). 1462–1470. 25 indexed citations

Mortazavi, Amir, Aasma Shaukat, James L. Kepner, et al.. (2005). Postoperative Computed Tomography Scan Surveillance for Patients With Stage II and III Colorectal Cancer. American Journal of Clinical Oncology. 28(1). 30–35. 10 indexed citations

Sunga, Annette Y., et al.. (2005). Carcinoembryonic antigen (CEA) surge in patients with metastatic colorectal cancer receiving systemic chemotherapy. Journal of Clinical Oncology. 23(16_suppl). 3615–3615.

Fakih, Marwan, Ashwani Rajput, Lakshmi Pendyala, et al.. (2005). A phase I and biological correlates study of capecitabine (CAP) + oxaliplatin (OX) + radiation therapy (RT) in locally advanced rectal cancer (LARC). Journal of Clinical Oncology. 23(16_suppl). 3633–3633. 2 indexed citations

James, Ted A., David G. Sheldon, Ashwani Rajput, et al.. (2004). Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer. 101(12). 2722–2726. 54 indexed citations

Sabel, Michael S., Judy L. Smith, Hector Nava, et al.. (2002). Esophageal resection for carcinoma in patients older than 70 years. Annals of Surgical Oncology. 9(2). 210–214. 73 indexed citations

10.

Leichman, Lawrence, Hector Nava, Leslie E. Blumenson, et al.. (2002). Effect of Concurrent Radiation Therapy and Chemotherapy on Pulmonary Function in Patients with Esophageal Cancer. The Cancer Journal. 8(6). 451–460. 25 indexed citations

11.

Chu, Quyen D., Hank C. Hill, Harold O. Douglass, et al.. (2002). Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas. Annals of Surgical Oncology. 9(9). 855–862. 115 indexed citations

12.

Hill, Hank C., et al.. (2002). High-grade dysplasia within Barrett's esophagus: Controversies regarding clinical opinions and approaches. Annals of Surgical Oncology. 9(3). 222–227. 20 indexed citations

13.

Chu, Quyen D., Judy L. Smith, Hector Nava, et al.. (2001). Is Glucagonoma of the Pancreas a Curable Disease?. International Journal of Gastrointestinal Cancer. 29(3). 155–162. 12 indexed citations

14.

Dougherty, Thomas J., Ravindra K. Pandey, Hector Nava, et al.. (2000). <title>Preliminary clinical data on a new photodynamic therapy photosensitizer: 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH) for treatment of obstructive esophageal cancer</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 3909. 25–27. 19 indexed citations

15.

Smith, Judy L., et al.. (1998). Carcinoma of the Gallbladder. Cancer Investigation. 16(1). 33–39. 25 indexed citations

16.

Sabel, Michael S. & Judy L. Smith. (1997). Principles of chronic venous access: recommendations based on the Roswell Park experience. Surgical Oncology. 6(3). 171–177. 6 indexed citations

17.

Smith, Judy L., et al.. (1996). Postoperative Complications After Splenectomy for Hematologic Malignancies. Annals of Surgery. 223(3). 290–296. 66 indexed citations

18.

Meropol, Neal J., Nicholas J. Petrelli, Miguel A. Rodrı́guez-Bigas, et al.. (1996). Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgery. The American Journal of Surgery. 172(3). 299–302. 5 indexed citations

19.

Jones, Mark P., Mitchell L. Schubert, & Judy L. Smith. (1991). Controversies, dilemmas, and dialogues. What do you recommend for prophylaxis in an elderly woman with arthritis requiring NSAIDs for control?. PubMed. 86(3). 264–8. 3 indexed citations

20.

Smith, Judy L., et al.. (1981). Radiation therapy for primary optic nerve meningiomas.. PubMed. 1(2). 85–99. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact